Zhenghai Zhang

Prof. Zhenghai Zhang

Daqing branch, Heilongjiang academy of sciences, Harbin, Heilongjiang, China
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2021 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
LWLian‐Hui Wei
Lian‐Hui Wei
YDYan Dong
Yan Dong
YSYu‐Feng Sun
Yu‐Feng Sun
XMXue‐Song Mei
Xue‐Song Mei
XMXue‐Song Ma
Xue‐Song Ma
SSShu‐Min Song
Shu‐Min Song
Foodborne protein hydrolysates exhibit biological activity that may be therapeutic in a number of human disease settings. Hemp peptides (HP) generated by controlled hydrolysis of hemp proteins have a number of health benefits and are of pharmaceutical value. In the present study, we produce small molecular weight HP from hemp seed and investigate its anticancer properties in Hep3B human liver cancer cells. We demonstrate that HP treatment increased apoptosis, reduced cell viability, and reduced cell migration in Hep3B human liver cancer cells without affecting the normal liver cell line L02. We correlate these phenotypes with increased cellular ROS levels, upregulation of cleaved caspase 3 and Bad, and downregulation of antiapoptotic Bcl‐2. HP treatment led to increased Akt and GSK‐3β phosphorylation, with subsequent downregulation of β‐catenin, suggesting β‐catenin signaling modulation as a critical mechanism by which HP exhibits anticancer properties. Our findings suggest HP are of potential therapeutic interest for liver cancer treatment.

5 January 2025 in Food Bioscience
Verified
Journal Article
Closed access
ZZZhenghai Zhang
Zhenghai Zhang
JGJingyi Ge
Jingyi Ge
LWLianhui Wei
Lianhui Wei
JSJie Shi
Jie Shi
YJYanru Ji
Yanru Ji
YDYan Dong
Yan Dong

1 February 2016 in Microbial Pathogenesis
Verified
Journal Article
Closed access
DYDi Yao
Di Yao
HZHua Zhang
Hua Zhang
XWXintong Wang
Xintong Wang
SYSimiao Yu
Simiao Yu
YWYuhua Wei
Yuhua Wei
YCYudong Cui
Yudong Cui

1 December 2015 in Microbial Pathogenesis
Verified
Journal Article
Closed access
SYSimiao Yu
Simiao Yu
HZHua Zhang
Hua Zhang
DYDi Yao
Di Yao
WLWei Liu
Wei Liu
XWXintong Wang
Xintong Wang
YCYudong Cui
Yudong Cui

1 August 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
JSJie Shi
Jie Shi
ZZZhenghai Zhang
Zhenghai Zhang
ZZZhenghai Zhang
Zhenghai Zhang
LWLianhui Wei
Lianhui Wei
YDYan Dong
Yan Dong
YJYanru Ji
Yanru Ji
This study aimed to investigate the antithrombotic activity of hemp seed peptides derived from trypsin hydrolysates and elucidate their molecular mechanisms using a ponatinib‐induced zebrafish (Danio rerio) thrombosis model. Through ultrafiltration and LC–MS/MS analysis, we identified 1741 peptide sequences (< 3 kDa), with 67% distributed in the 0.5–1.5 kDa range. In vivo experiments demonstrated that 125 μg/mL hemp seed peptides significantly ameliorated ponatinib‐induced thrombosis by increasing 16.55% cardiac erythrocyte staining intensity, enhancing 54.8% blood flow velocity, and restoring 11.2% intersegmental blood vessel diameters. In addition, the observed anticoagulant effect may be partially attributed to upregulated expression levels of vascular endothelial growth factor receptor 1 (vegfr1) and down‐regulated expression levels of cysteinyl aspartate‐specific proteinase‐3 (caspase‐3) at the mRNA level. These findings propose hemp seed peptides as novel dietary antithrombotic agents with potential applications in functional food development.